Reactions 1680, p180 - 2 Dec 2017 Acute disseminated encephalomyelitis: case report A 55-year-old woman developed acute disseminated encephalomyelitis (ADEM) following the administration of seasonal influenza virus vaccine. The woman, who was wheel chair bound, had a history of traumatic cervical spinal cord injury. She presented with fever and confusion. Subsequently, she was hospitalised. A month prior to the presentation, she was administered a seasonal influenza virus vaccine [route and dosage not stated]. Her neurological examination showed Babinski sign with quadriplegia and hyper-reflexia of limb tendons. CSF analysis resulted in pleocytosis with glucose content of 88 g/dL and protein content of 108 g/dL. Thereafter, she underwent MRI scan of the brain, which showed the images of ADEM. The woman was started on steroid pulse therapy, and significant improvement was noted after five days. She recovered completely in the following two weeks. Author comment: "This case elucidates the occurrence risk of ADEM in patients with altered mental status after seasonal influenza vaccination, emphasizing the importance of recognizing recent vaccination exposures. . .The vaccines against seasonal influenza are the most frequently reported to be associated with ADEM." Choi K-H, et al. Altered mental status after seasonal influenza vaccination. Journal of Clinical Neuroscience 43: 118, Sep 2017. Available from: URL: http:// doi.org/10.1016/j.jocn.2017.03.020 - South Korea 803285115 0114-9954/17/1680-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved Reactions 2 Dec 2017 No. 1680
Reactions Weekly – Springer Journals
Published: Dec 2, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud